SpringWorks Therapeutics, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -174.33 M

SpringWorks Therapeutics, Inc. Free Cash Flow is USD -174.33 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -28.81% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • SpringWorks Therapeutics, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -244.89 M, a 32.03% change year over year.
  • SpringWorks Therapeutics, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -185.48 M, a 16.06% change year over year.
  • SpringWorks Therapeutics, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -159.82 M, a 327.05% change year over year.
  • SpringWorks Therapeutics, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -37.42 M, a -34.61% change year over year.
Key Data
Date Free Cash Flow Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities